Mesoporous Silica as a Carrier for Amorphous Solid Dispersion
Open Access
- 10 January 2017
- journal article
- Published by Sciencedomain International in British Journal of Pharmaceutical Research
- Vol. 16 (6) , 1-19
Abstract
In the past decade, the discovery of active pharmaceutical substances with high therapeutic value but poor aqueous solubility has increased, thus making it challenging to formulate these compounds as oral dosage forms. The bioavailability of these drugs can be increased by formulating these drugs as an amorphous drug delivery system. Use of porous media like mesoporous silica has been investigated as a potential means to increase the solubility of poorly soluble drugs and to stabilize the amorphous drug delivery system. These materials have nanosized capillaries and the large surface area which enable the materials to accommodate high drug loading and promote the controlled and fast release. Therefore, mesoporous silica has been used as a carrier in the solid dispersion to form an amorphous solid dispersion (ASD). Mesoporous silica is also being used as an adsorbent in a conventional solid dispersion, which has many useful aspects. This review focuses on the use of mesoporous silica in ASD as potential means to increase the dissolution rate and to provide or increase the stability of the ASD. First, an overview of mesoporous silica and the classification is discussed. Subsequently, methods of drug incorporation, the stability of dispersion and, much more are discussed.Keywords
All Related Versions
This publication has 105 references indexed in Scilit:
- Ordered Mesoporous Silica Material SBA-15: A Broad-Spectrum Formulation Platform for Poorly Soluble DrugsJournal of Pharmaceutical Sciences, 2009
- Characterization and Optimization of AMG 517 Supersaturatable Self‐Emulsifying Drug Delivery System (S‐SEDDS) for Improved Oral AbsorptionJournal of Pharmaceutical Sciences, 2009
- Uniform Rattle‐type Hollow Magnetic Mesoporous Spheres as Drug Delivery Carriers and their Sustained‐Release PropertyAdvanced Functional Materials, 2008
- Mesoporous Silicon in Drug Delivery ApplicationsJournal of Pharmaceutical Sciences, 2008
- Combined Use of Crystalline Salt Forms and Precipitation Inhibitors to Improve Oral Absorption of Celecoxib from Solid Oral FormulationsJournal of Pharmaceutical Sciences, 2007
- Influence of Different Polymers on the Crystallization Tendency of Molecularly Dispersed Amorphous FelodipineJournal of Pharmaceutical Sciences, 2006
- Ordered Mesoporous Materials in the Context of Drug Delivery Systems and Bone Tissue EngineeringChemistry – A European Journal, 2006
- Development of a supersaturable SEDDS (S‐SEDDS) formulation of paclitaxel with improved oral bioavailabilityJournal of Pharmaceutical Sciences, 2003
- Explanation of the Crystallization Rate of Amorphous Nifedipine and Phenobarbital from Their Molecular Mobility as Measured by 13C Nuclear Magnetic Resonance Relaxation Time and the Relaxation Time Obtained from the Heating Rate Dependence of the Glass Transition TemperatureJournal of Pharmaceutical Sciences, 2001
- Ueber DiffusionAnnalen der Physik, 1855